NeoGenomics (NASDAQ:NEO) Trading Down 7.7% After Analyst Downgrade

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) shares dropped 7.7% on Tuesday after Needham & Company LLC lowered their price target on the stock from $24.00 to $19.00. Needham & Company LLC currently has a buy rating on the stock. NeoGenomics traded as low as $13.70 and last traded at $14.05. Approximately 252,873 shares changed […]

Related Keywords

United States ,United Kingdom ,Aliciac Olivo ,William Blair ,Piper Sandler ,Goldman Sachs Group ,Neogenomics Inc ,Nasdaq ,Financial Services Group Inc ,Clinical Services ,Securities Exchange Commission ,Bluepath Capital Management ,Quadrant Capital Group ,Needham Company ,Burkett Financial Services ,Get Free Report ,General Counsel Alicia ,Exchange Commission ,Path Capital Management ,Financial Services ,Capital Group ,Services Group ,Genomics Trading Down ,Advanced Diagnostics ,Neogenomics Daily ,